Atrás
Epigenomics AG (EPGNF) Ganando
Gráfico del Precio de Acciones EPGNF
EPGNF Ganando
Epigenomics AG
$1.12
0%
$0
Hasta hoy:Mar 26, 11:28:48 GMT-4
Estadísticas clave
Cierre Anterior
$1.12
Precio de apertura
$1.12
Rango del día
$1.12 - $1.12
Rango de 52 semanas
$0.79 - $1.12
Volumen
380
Volumen promedio
0
Rendimiento de dividendos
--
EPS (TTM)
-3.69
Cap. de mercado
$982.1K
¿Qué es Epigenomics AG?
Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. The company is headquartered in Heidelberg, Baden-Wuerttemberg and currently employs 3 full-time employees. The company went IPO on 2004-07-19. The company develops and commercializes blood-based diagnostic products across multiple cancer indications. The firm's main product is Epi proColon, a blood test for colorectal cancer screening. Along with the blood-based tests the Company offers services related to research, product development, regulatory approval and manufacturing of in-vitro diagnostic (IVD) products. The company also offers Epi proLung, a blood-based test that detects the presence of lung cancer in blood plasma. The firm is present in Europe and the United States.
Características
© 2026 Finture Development Limited. Todos los derechos reservados.